Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Buchanan Ocular Therapeutics Unit,
Department of Ophthalmology and the New Zealand National Eye Centre,
Buchanan Ocular Therapeutics Unit, Department of Ophthalmology and the New Zealand National Eye Centre
PhD Student at the University of Auckland
Connexin43 hemichannel block inhibits NLRP3 inflammasome activation in a human retinal explant model of diabetic retinopathy.
Experimental eye research 01, 2021 | Pubmed ID: 33285185
University of Auckland
Charisse Y. J. Kuo*,1,
Henry H. Louie1,
Ilva D. Rupenthal1,
Odunayo O. Mugisho*,1
1Buchanan Ocular Therapeutics Unit, Department of Ophthalmology and the New Zealand National Eye Centre, University of Auckland
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.